Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Slingshot Biosciences, Inc.

Slingshot Biosciences, Inc.

Stage unknownEmeryville, CAslingshot.bioOther
Facts
Year of incorporation
unknown
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
1
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
1
Financing history
1 rounds
  1. Jan 24, 2023
    Form D equity offering · $26.2M (form d sold) · 10 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Slingshot Biosciences, Inc. filed Form D/A: $26,227,275 sold of $26,227,275, Other”
Investors on record
1 edges
People
1 officers, 5 directors
Timeline
1
  1. Apr 26, 2024
    Slingshot Biosciences, Inc. filed Form D/A: $26,227,275 sold of $26,227,275, Other
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
17 observations
Every observation on this company